EVALUATION OF QUALITY CHARACTERISTICS OF COLLECTED UMBILICAL CORD TISSUE AT BUU DIEN HOSPITAL

Văn Long Nguyễn, Minh Đức Nguyễn, Văn Hoàng Nguyễn, Hồng Hà Phạm, Hồng Trường Nguyễn, Trần Thanh Quý Phan, Hoàng Việt Nguyễn, Thị Hà Vũ

Main Article Content

Abstract

Umbilical cord tissue has been a potential source of mesenchymal stem cells for regenerative medicine and therapy for decades. However, the process of collecting umbilical cord tissue always has the risk of poor sample quality and the incidence of fungal and bacterial infections that can affect the preservation and future treatment process. This study was conducted to evaluate the initial quality of umbilical cord tissue collected and finding the role of the factors and the results in collected umbilical cord tissue. A cross-sectional descriptive study on 126 umbilical cord tissue samples collected for autologous purposes at Stem cell and Genetic Center, Buu Dien Hospital from April 2023 to April 2024. Results showed that the proportion of boys is higher than girls (65.1% and 34.9%). The majority of second-born babies had umbilical cord tissue saved (71.6%). The average age of pregnant women with umbilical cord tissue saved was 32.9 ± 5.8 years old. The average age of the fetus at birth is 38.2 ± 1.2 weeks, highest in the 37 - 38 weeks group, is about 51.3%. Microbiological testing showed 1 sample positive with bacteria and fungi with the proportion is 0.8%. All samples have standard color, freshness, size and shape.

Article Details

References

Forraz N, McGuckin CP. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif. 2011;44(Suppl 1):60-69. doi:10.1111/j.1365-2184.2010.00729.x
2. Drobiova H, Sindhu S, Ahmad R, Haddad D, Al-Mulla F, Madhoun AA. Wharton’s jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications. Front Cell Dev Biol. 2023;11. doi:10.3389/ fcell.2023.1211217
3. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317. doi:10.1080/ 14653240600855905
4. Trounson A, Thakar RG, Lomax G, Gibbons D. Clinical trials for stem cell therapies. BMC Med. 2011;9(1):52. doi:10.1186/1741-7015-9-52
5. González-González A, García-Sánchez D, Dotta M, Rodríguez-Rey JC, Pérez-Campo FM. Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine. World J Stem Cells. 2020;12(12):1529. doi:10. 4252/wjsc.v12.i12.1529
6. Raileanu VN, Whiteley J, Chow T, et al. Banking Mesenchymal Stromal Cells from Umbilical Cord Tissue: Large Sample Size Analysis Reveals Consistency Between Donors. Stem Cells Transl Med. 2019;8(10):1041-1054. doi:10.1002/ sctm.19-0022
7. Gil-Kulik P, Świstowska M, Krzyżanowski A, et al. Evaluation of the Impact of Pregnancy-Associated Factors on the Quality of Wharton’s Jelly-Derived Stem Cells Using SOX2 Gene Expression as a Marker. Int J Mol Sci. 2022;23(14):7630. doi:10.3390/ijms23147630
8. Gil-Kulik P, Świstowska M, Kondracka A, et al. Increased Expression of BIRC2, BIRC3, and BIRC5 from the IAP Family in Mesenchymal Stem Cells of the Umbilical Cord Wharton’s Jelly (WJSC) in Younger Women Giving Birth Naturally. Oxid Med Cell Longev. 2020;2020:e9084730. doi:10.1155/2020/9084730
9. Raffo D, Maglioco A, Fernandez Sasso D. A protocol for umbilical cord tissue cryopreservation as a source of mesenchymal stem cells. Mol Biol Rep. 2021;48(2):1559-1565. doi:10.1007/s11033-020-06079-x
10. Đinh Thị Hồng. Nghiên Cứu Tình Hình Nhiễm Khuẩn Đường Sinh Dục Dưới ở Thai Phụ Trong 3 Tháng Cuối Của Thai Kỳ Tại Bệnh Viện Phụ Sản Trung Ương. Luận văn tốt nghiệp bác sỹ nội trú các bệnh viện. Trường Đại học Y Hà Nội; 2004.